10 Best Electric Utility Stocks To Buy Right Now

Related UNFI United Natural Foods Just Posted A 6-Month High Off Strong Earnings Report 4 Stocks Moving In Monday's After-Hours Session United Natural Foods' (UNFI) CEO Steve Spinner on Q3 2016 Results – Earnings Call Transcript (Seeking Alpha) Related BBRY Tesla's Gigafactory: Are Other Auto Manufacturers About To Experience Their 'Blackberry Moment?' BlackBerry Just Has 'Too Many Headwinds'; Macquarie Starts Coverage At Underperform The Vetr community has upgraded $BBRY to 5-Stars. (Vetr)

Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday's regular session.

United Natural Foods, Inc. (NASDAQ: UNFI) Jul16 40.0 Calls: 900 @ ASK $1.85: 2042 traded vs 24 OI: $39.15 Ref BlackBerry Ltd (NASDAQ: BBRY) Aug16 8.0 Calls: 4000 @ ASK $0.27: 4028 traded vs 595 OI: Earnings 6/23 Before Open $7.38 Ref Starbucks Corporation (NASDAQ: SBUX) Fri 7/22 $56.0 Calls (Wkly) Sweep: 967 @ ASK $1.31: 7682 traded vs 44 OI: Earnings 7/28 $55.21 Ref MGM Resorts International (NYSE: MGM) Jun16 25.0 Calls: 813 @ ASK $0.21: 11k traded vs 2719 OI: $24.01 Ref Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Jul16 40.0 Calls: 500 @ Above Ask! $8.30: 500 traded vs 0 OI: $41.88 Ref

Posted-In: Call optionsNews Options Markets

10 Best Electric Utility Stocks To Buy Right Now: Coherent, Inc.(COHR)

Coherent, Inc., incorporated on January 11, 1989, is a supplier of photonics-based solutions for a range of commercial and scientific research applications. The Company designs, manufactures, services and markets lasers and related accessories to customers. The Company operates in two segments: Specialty Lasers and Systems (SLS) and Commercial Lasers and Components (CLC).

The Company offers products for a number of markets, such as Microelectronics, Materials Processing, OEM (original equipment manufacturer) Components and Instrumentation, and Scientific Research and Government Programs. The Company supports three markets in the microelectronics industry: flat panel display (FPDs) manufacturing, advanced packaging and interconnects and semiconductor front-end.

The Company supplies high power lasers for metal processing and low-to-medium power lasers for laser marking, non-metals processing and precision micromachining. The Companys high power i ndustrial laser systems are used for cutting, welding, cladding and hardening of metals, as well as other materials processing applications. The Semiconductor business provides power arrays with powers in excess of 50 kilowatts through cooling and stacking technology. The fiber lasers are used for metal cutting, cladding and welding applications.

The Company offers products for instrumentation applications in the materials processing market, including bio-instrumentation, medical OEMs, graphic arts and display and machine vision. The Company also supports the laser-based instrumentation market with a range of laser-related components, including diode lasers for optical pumping. The Companys OEM component business includes sales to other, less integrated laser manufacturers participating in OEM markets, such as materials processing, scientific, and medical.

Bio-instrumentation applications of the Companys lasers include bio-agent detection for point source and standoff detection of pathogens or other bi! o-toxins; confocal microscopy for biological imaging that allows researchers and clinicians to visualize cellular and subcellular structures and processes with an incredible amount of detail, and DNA sequencing that provides automation and data acquisition rates.

The Company sells components and lasers to medical laser companies in end-user applications, such as ophthalmology, aesthetic, surgical, therapeutic and dentistry.

Specialty Lasers and Systems

The SLS segment develops and manufactures configurable products serving the microelectronics, scientific research and government programs and original equipment manufacturer (OEM) components and instrumentation markets.

Commercial Lasers and Components

The CLC segments primary markets include materials processing, OEM components and instrumentation and microelectronics.

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Rofin-Sinar Technologies (NASDAQ: RSTI) got a boost, shooting up 37 percent to $31.50 as Coherent, Inc. (NASDAQ: COHR) announced its plans to buy Rofin-Sinar Technologies Inc in a deal valued at around $942 million.

10 Best Electric Utility Stocks To Buy Right Now: Ubiquiti Networks, Inc.(UBNT)

 

Ubiquiti Networks, Inc. provides networking products and solutions for service providers and enterprises worldwide. Its service provider product platforms provide carrier-class network infrastructure for fixed wireless broadband, wireless backhaul systems, and routing; and enterprise product platforms offer wireless LAN infrastructure, video surveillance products, VOIP phones, switches, and machine-to-machine communication components. The companys products and solutions include high performance radios, antennas, software, communications protocols, and management tools designed to deliver carrier and enterprise class wireless broadband access and other services primarily in the unlicensed RF spectrum. It provides technology platforms, such as airMAX platform, which includes proprietary protocols that contain technologies for minimizing signal noise; EdgeMAX, a disruptive price-performance software and systems routing platform ; and airFiber, a point-to-point radio system. The company also offers UniFi Enterprise Wi-Fi System that includes Wi-Fi certified hardware with a software based management controller; UniFi Video H.264 megapixel IP cameras; and UniFi Video management software controller to manage multiple UniFi Video H.264 IP cameras and digital video recorder devices. In addition, it provides UniFi VOIP Phone, an enterprise desktop smartphone designed to integrate into the UniFi Enterprise System; UniFi Switches to deliver performance, switching, and PoE+ support for enterprise networks; and mFi, which includes hardware sensors, power devices, and management software that allows devices to be monitored and controlled remotely through Wi-Fi. Further, the company provides embedded radio products; and mounting brackets, cables, and power over Ethernet adapters. The company was formerly known as Pera Networks, Inc. and changed its name to Ubiquiti Networks, Inc. in 2005. Ubiquiti Networks, Inc . was incorporated in 2003 and is headquartered in San Jose,! California.

Advisors’ Opinion:

  • [By Mani]

    Ubiquiti Networks, Inc. (NASDAQ:UBNT) shares have been in rally mode, particularly since reporting strong quarterly results in August, gaining 57 percent. Over the past three months, shares have climbed nearly 100 percent versus a 9 percent gain in the NASDAQ.

  • [By Jon C. Ogg]

    Ubiquiti Networks Inc. (NASDAQ: UBNT) was given a cautious Neutral rating as well, and it had the least negative bias in Garcha’s call. He said:

Best Prefered Companies To Buy Right Now: J & J Snack Foods Corp.(JJSF)

J & J Snack Foods Corp. (J & J), incorporated in 1971, manufactures nutritional snack foods and distributes frozen beverages. The Company operates in three business segments: Food Service, Retail Supermarkets and Frozen Beverages. It is a manufacturer of soft pretzels in the United States, Mexico and Canada. The Company sells other products, including soft drinks, funnel cakes under the FUNNEL CAKE FACTORY brand name and smaller amounts of various other food products. The Company markets its products across the nation to the food service and retail supermarket industries.

The Company sells its soft pretzels under the brand names, such as PRETZEL FILLERS, PRETZELFILS, GOURMET TWISTS, MR. TWISTER, SOFT PRETZEL BITES, SOFTSTIX, SOFT PRETZEL BUNS, TEXAS TWIST,BAVARIAN BAKERY,SUPERPRETZEL BAVARIAN, NEW YORK PRETZEL, KIM & SCOTT’S GOURMET PRETZELS and SERIOUSLY TWISTED!. The Company’s frozen juice treats and desserts are marketed primarily under the LUIGI’S, WHOLE F RUIT, PHILLY SWIRL, ICEE and MINUTE MAID brand names. The Company’s churros are sold primarily under the TIO PEPE’S, CALIFORNIA CHURROS and OREO brand names. The Company’s dough enrobed handheld products are marketed under the PATIO, SUPREME STUFFERS and SWEET STUFFERS brand names, and under private labels. The Company’s bakery products are marketed under the MRS. GOODCOOKIE, READI-BAKE, COUNTRY HOME, MARY B’S and DADDY RAY’S brand names, and under private labels. Its bakery products include primarily biscuits, fig and fruit bars, cookies, breads, rolls, crumb, muffins and donuts.

Food Service

The Company’s food service segment is engaged in selling primary products, such as soft pretzels, frozen juice treats and desserts, churros, dough enrobed handheld products and baked goods. Its customers in the food service segment include snack bars and food stands in chain, department and discount stores; malls and shopping centers; casual dining restaurants ; fast food outlets; stadiums and sports arenas; leisure and! theme parks; convenience stores; movie theatres; warehouse club stores, and schools, colleges and other institutions. Within the food service industry, its products are purchased by the consumer primarily for consumption at the point-of-sale.

Retail Supermarkets

The primary products sold to the retail supermarket channel are soft pretzel products, including SUPERPRETZEL, frozen juice treats and desserts, including LUIGI’S Real Italian Ice, MINUTE MAID Juice Bars and Soft Frozen Lemonade, WHOLE FRUIT frozen fruit bars and sorbet, PHILLY SWIRL cups and sticks, ICEE Squeeze-Up Tubes, and dough enrobed handheld products, including PATIO burritos. Within the retail supermarket channel, its frozen and prepackaged products are purchased by the consumer for consumption at home.

Frozen Beverages

The Company sells frozen beverages to the food service industry primarily under the names ICEE, SLUSH PUPPIE and PARROT ICE in the United States, Mexico and Canada. It also provides repair and maintenance service to customers for customers’ owned equipment.

Advisors’ Opinion:

  • [By Monica Gerson]

    J & J Snack Foods Corp (NASDAQ: JJSF) is estimated to post its quarterly earnings at $0.78 per share on revenue of $231.58 million.

    Nabors Industries Ltd. (NYSE: NBR) is expected to post a quarterly loss at $0.33 per share on revenue of $630.85 million.

10 Best Electric Utility Stocks To Buy Right Now: Biogen Idec Inc(BIIB)

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Its marketed products include the AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkin?s lymphoma (NHL); TYSABRI to treat relapsing MS; FUMADERM for the treatment of severe plaque psoriasis in adult patients; and FAMPYRA, an oral compound for the improvement of walking in adult patients with MS with walking disability. Biogen Idec Inc.?s products under Phase III consist of PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; Long-lasting factor IX and VIII fusion protein for the treatment of hemophilia B; GA101, a monoclonal antibody for t h e treatment of chronic lymphocytic leukemia and NHL; and Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis. The company?s Phase I clinical trial products include Anti-LINGO for use in multiple sclerosis, Neublastin for use in neuropathic pain, CD40L for use in systemic lupus erythematosus, ANTI-TWAEK humanized monoclonal antibody for TWEAK, and BIIB037 for use in Alzheimer’s disease; and Phase II clinical trial product comprises OCRELIZUMAB, a humanized monoclonal antibody for treating CD20. It has collaboration agreements with Genentech, Inc.; Elan Pharma International, Ltd; Acorda Therapeutics, Inc.; Portola Pharmaceuticals, Inc.; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; and Vernalis plc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is headquartered in Weston, Massachusetts.

Advisors’ Opinion:

  • [By Ben Levisohn]

    With biotech stocks like Alexion Pharmaceuticals (ALXN), Biogen (BIIB), Amgen (AMGN), Celgene (CELG) and Gilead Sciences (GILD) getting pounded following Britain’s decision to embrace the Brexit, Piper Jaffray’s Joshua Schimmer and team assess the damage:

  • [By Johanna Bennett]

    The earnings season for Big Biotech kicks of later this month when Biogen (BIIB) unveils second quarter financial results on July 21. But will those reports be enough to reverse the negative sentiment surrounding the sector?

    The biotech analyst team at Cowen expects strong earnings driven by ,solid demand, an open pricing environment in the U.S. and a currency tailwind. But, they warn, the sector may lack sizzle.

    Steady financial performance in the absence of an exciting new product cycle may not be enough to overcome negative sentiment toward the groupInvestors are increasingly of the view that biotech fundamentals have deteriorated. They cite disappointing drug launches, a lack of pipeline catalysts, heightened payor pressures, and earnings growth that appears more dependent on financial engineering. While we admit that biotech is lacking an exciting new product cycle, we are not aware of any changes to the drug development process or commercial landscape that could have altered the industry’s fundamental value proposition. Rather we suspect that poor stock performance and investor sentiment may be engendering a “glass half empty” view toward fundamentals that are largely unchanged relative to a year ago when investors were touting biotech for its innovation cycle and increased R&D productivity. Earnings are the most objective metric for gauging perfor mance, and we expect Q2 to support the notion that biotech’s growth outlook and value proposition remain favorable relative to other sectors. As such, Q2 should provide the sector with a firmer level of support. However, more substantial upside is likely to be dependent on a change in sentiment, which is subjective and always difficult to predict in terms of timing.

    Which names are the best plays?

    According to Cowen, names with the potential to report Q2 results in excess of consensus include Acorda Therapeutics (ACOR), Alexion (ALXN), Biogen,

  • [By Ben Levisohn]

    Catalysts remain significant for the biotech industry: The biotech industry
    obviously remains open to swings given the political landscape. That said,
    fundamental catalysts for new drugs are also beginning to favor biotech again
    with PCSK9 outcomes studies, new drug launches from Regeneron (REGN), Amgen (AMGN) and Biogen (BIIB) possible in 2017 and key PhIII readouts for Celgene (CELG) and Incyte (INCY) in 2017.

  • [By Ben Levisohn]

    Johnson & Johnson (JNJ) now has a market cap of $308 billion dollars, just a smidgen less than that of Gilead Sciences (GILD), Biogen (BIIB), Mylan (MYL), Celgene (CELG) and Teva Pharmaceutical Industries (TEVA) combined. It’s time to sell, says Standpoint Research’s Ronnie Moas:

10 Best Electric Utility Stocks To Buy Right Now: Advanced Energy Industries, Inc.(AEIS)

 

Advanced Energy Industries, Inc., together with its subsidiaries, designs, manufactures, sells, and supports power conversion products and solutions that transform power into various usable forms. The company offers thin film deposition power conversion systems, including direct current (DC), pulsed DC low frequency, high voltage, and radio frequency (RF) power supplies, as well as matching networks and remote plasma sources for reactive gas applications and RF instrumentation. Its power conversion systems are used by semiconductor, solar panel, and similar thin film manufacturers, including flat panel display, data storage, industrial hard coating and ophthalmic optical coating equipment makers, and architectural glass manufacturers. The company also provides power control modules and thermal instrumentation products for rapid thermal processing, chemical vapor deposition, crystal growing, and other semiconductor and solar ap plications, as well as in chemical processing, glass manufacturing, and other general industrial power applications. In addition, it offers repair, conversions, upgrades, and refurbishments services. The company markets and sells its products through direct sales force, independent sales representatives, and distributors in North America, Europe, and Asia. Advanced Energy Industries, Inc. was founded in 1981 and is headquartered in Fort Collins, Colorado.

Advisors’ Opinion:

  • [By Nelson Hem]

    While short sellers shied away from many of the leading solar stocks between the January 15 and January 29 settlement dates, two companies in particular led that trend. The number of Advanced Energy Industries, Inc. (NASDAQ: AEIS) and Sunedison Inc (NYSE: SUNE) shares sold short shrank by more than 10 percent by the end of the month.

10 Best Electric Utility Stocks To Buy Right Now: Reinsurance Group of America, Incorporated(RGA)

 

Reinsurance Group of America, Incorporated engages in reinsurance business. It offers individual and group life and health insurance products, including term life, credit life, universal life, whole life, group life and health, joint and last survivor insurance, critical illness, disability, and longevity products, as well as asset-intensive and financial reinsurance products. The company also provides reinsurance for mortality, morbidity, and lapse risk associated with products; and reinsurance for investment-related risks, as well as develops and markets technology solutions for the insurance industry. It serves life insurance companies in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. Reinsurance Group of America, Incorporated was founded in 1973 and is headquartered in Chesterfield, Missouri.

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Morgan Stanley downgraded Chipotle (NYSE: CMG) to Equal-Weight.
    UBS downgraded AMC Networks (NASDAQ: AMCX) to Sell.
    Citi upgraded Sealed Air (NYSE: SEE) to Buy.
    Goldman Sachs upgraded Reinsurance Group (NYSE: RGA) to Buy.

  • [By David Sterman]

    My favorite insurers: AIG (NYSE: AIG) (which I discussed a few months ago), Protective Life (NYSE: PL) and Reinsurance Group of America (NYSE: RGA).

10 Best Electric Utility Stocks To Buy Right Now: Myriad Genetics, Inc.(MYGN)

Myriad Genetics, Inc. (Myriad), incorporated on November 6, 1992, is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual’s risk for developing disease later in life, identify a patient’s likelihood of responding to drug therapy and guide a patient’s dosing to enable optimal treatment, or assess a patient’s risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology. Myriad offers diagnostic tests for a range of dise ases, such as Myriad myRisk Hereditary Cancer test for hereditary breast cancer, hereditary ovarian cancer, hereditary pancreatic cancer, hereditary uterine (endometrial) cancer and hereditary colon cancer; Myriad myPlan Lung Cancer test for lung cancer; Myriad myPath Melanoma test for melanoma; Prolaris test for prostate cancer, and Vectra DA for rheumatoid arthritis (RA).

Molecular Diagnostic Testing

The Company’s molecular diagnostic tests are designed to analyze genes, their expression levels and corresponding proteins. Myriad’s primary molecular diagnostic tests include myRisk Hereditary Cancer, a deoxyribonucleic acid (DNA) sequencing test for assessing the risks for hereditary cancers, such as breast cancer, ovarian cancer, colon cancer, uterine cancer, melanoma, pancreatic cancer, prostate cancer and gastric cancer; BRACAnalysis, a DNA sequencing test for assessing the risk of developing breast and ovarian cancer; BART, a DNA sequencing test for hereditary breast and ovarian cancer; BRACAnalysis CDx ! , a DNA sequencing test for use as a companion diagnostic with the poly (ADP-ribose) polymerase (PARP) inhibitor LynparzaTM (olaparib); Tumor BRACAnalysis CDx, a DNA sequencing test designed to be utilized to predict response to DNA damaging agents, such as platinum-based chemotherapy agents and PARP inhibitors; COLARIS, a DNA sequencing test for assessing the risk of colorectal and uterine cancer; COLARIS AP, a DNA sequencing test for assessing the risk of colorectal cancer; Vectra DA, a protein detection test for assessing the disease activity of rheumatoid arthritis; Prolaris, a ribonucleic acid (RNA) expression test for assessing the aggressiveness of prostate cancer; EndoPredict, an RNA expression test for assessing the aggressiveness of breast cancer; myPath Melanoma, an RNA expression test for diagnosing melanoma, and myPlan Lung Cancer, an RNA expression test for assessing the aggressiveness of lung cancer.

Pharmaceutical and Clinical Services

The Company provides a range of pharmaceutical and clinical services. Through its subsidiary, Myriad RBM, Inc., Myriad provides biomarker discovery and pharmaceutical and clinical services to the pharmaceutical, biotechnology and medical research industries utilizing its multiplexed immunoassay technology. The Company also owns Privatklinik Dr. Robert Schindlbeck GmbH & Co. KG, located approximately 15 miles from the Company’s European laboratories in Munich, Germany. The Company’s technology enables it to screen sets of well-characterized clinical samples from both diseased and non-diseased populations against its menu of biomarkers.

Advisors’ Opinion:

  • [By Ben Levisohn]

    We took in Walt Disney (DIS) earnings, Argus’ downgrade of Noble (NE), and Myriad Genetics’ (MYGN) freefall.

    We looked at the speculation that International Paper (IP) could be a takeover target, and the progress made at Ralph Lauren (RL), and the slowing same-store sales at Shake Shack (SHAK).

10 Best Electric Utility Stocks To Buy Right Now: Stamps.com Inc.(STMP)

 

Stamps.com Inc. provides Internet-based postage solutions in the United States. It offers solutions for mailing and shipping various mail pieces, such as postcards, envelopes, flats, and packages using a range of United States Postal Service (USPS) mail classes, including First Class Mail, Priority Mail, Priority Mail Express, Media Mail, Parcel Select, and others. The companys products and services comprise USPS approved PC Postage service that enables users to print electronic stamps directly onto envelopes, plain paper, or labels using personal computer, printer, and Internet connection. It also provides multi carrier shipping solutions under the ShipStation and ShipWorks brands; mailing and shipping integrations solutions comprising electronic postage for transactions to partners who manage the front-end process; sells NetStamps labels, DYMO Stamp labels, shipping labels, other mailing labels, dedicated postage printers, scales, and other mailing and shipping-focused office supplies through its mailing and shipping supplies store; and Stamps.com branded insurance to insure mails or packages. In addition, the company offers PhotoStamps, a patented form of postage service, which allows consumers to turn digital photos, designs, or images into USPS-approved postages. It serves individuals, small businesses, home offices, medium-size businesses, and large enterprises. The company was formerly known as StampMaster, Inc. and changed its name to Stamps.com Inc. in December 1998. Stamps.com Inc. was founded in 1996 and is headquartered in El Segundo, California.

Advisors’ Opinion:

  • [By Javier Hasse]

    Other stocks moving in Friday’s after-hours session included:

    A. O. Smith Corp (NYSE: AOS), down 2.5 percent Pan American Silver Corp. (USA) (NASDAQ: PAAS), down 2.1 percent Stamps.com Inc. (NASDAQ: STMP), up 1.87 percent

    Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

10 Best Electric Utility Stocks To Buy Right Now: Bed Bath & Beyond Inc.(BBBY)

Bed Bath & Beyond Inc., incorporated on October 5, 1971, is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market). The Company operates in two segments: North American Retail and Institutional Sales.

The Company’s customers can purchase products from the Company either in-store, online, with a mobile device or through a contact center. The Company also operates Linen Holdings, a provider of a range of textile products, amenities and other goods to institutional customers in the hospitality, cruise line, healthcare and other industries. Additionally, the Company is a partner in a joint venture, which operates approximately seven retail stores in Mexico under the name Bed Bath & Beyond.

The Company sells a range of domestics merchandise and home furnishings. Domestics merchandise includes categories, such as bed linens and related items, bath items and kitchen textiles. Home furnishings include categories, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables and juvenile products.

The Company operates approximately 1,530 stores plus its various Websites, other interactive platforms and distribution facilities. The Company’s over 1,530 stores operate in approximately 50 states, the District of Columbia, Puerto Rico and Canada, including over 1,020 BBB stores, approximately 280 Cost Plus World Market stores, over 100 Baby stores, approximately 80 CTS stores and over 50 Harmon stores. The Company’s stores range in size from approximately 5,000 to 100,000 square feet. The Company has distribution facilities, which ship merchandise to stores and customers, totaling approximately 6.1 million square f eet consisting of over three owned and approximately 10 leas! ed facilities. The Company has approximately 813,000 square feet within over 20 leased and owned facilities for procurement and corporate office functions. In addition, the Company has over seven locations, totaling approximately 14,000 square feet, which are utilized primarily for institutional sales related functions.

Advisors’ Opinion:

  • [By Monica Gerson]

    Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported stronger-than-expected earnings for its fourth quarter and declared its first-ever quarterly dividend of $0.125 per share. Bed Bath & Beyond shares surged 4.49 percent to $51.00 in the after-hours trading session.

10 Best Electric Utility Stocks To Buy Right Now: Medidata Solutions, Inc.(MDSO)

 

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences in the United States and internationally. The company offers applications and data analytics for clinical development. It offers Medidata Rave, a platform for capturing, managing, and reporting clinical data; Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, which enhances the efficiency of clinical trial start-up; Medidata Insights, a clinical business analytics platform; and Medidata Balance, a randomization and trial supply management solution. The company also provides Medidata Patient Cloud application for electronic patient-reported outcome; Medidata Grants Manager, which enables to develop and manage trial budgets; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and Medidata SQM, a set of c loud-based site quality management dashboards. In addition, it offers Medidata Coder that provides medical coding and synonym management solutions; Medidata Safety Gateway, which offers a solution for collecting and transmitting adverse events and related data from the EDC system; and Medidata Targeted SDV that provides auditable and scalable solutions, as well as offers hosting, support, and professional services. Medidata Solutions, Inc. markets and sells its cloud-based solutions through direct sales force, as well as through relationships with CROs and other strategic partners. The company serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and academic institutions, contract research organizations, and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Lisa Levin]

    On Wednesday, technology shares climbed by 0.94 percent. Top gainers in the sector included Marvell Technology Group Ltd. (NASDAQ: MRVL) and Medidata Solutions Inc (NASDAQ: MDSO).